Hypertension control and antihypertensive therapy in patients with chronic kidney disease
- PMID: 25421796
- DOI: 10.1093/ajh/hpu215
Hypertension control and antihypertensive therapy in patients with chronic kidney disease
Abstract
Background: Hypertension is a major risk factor in the progression of chronic kidney disease (CKD). Although hypertension is more prevalent and treated more often among CKD patients, it is less likely to be controlled. Current guidelines recommend the use of multiple antihypertensive agents to achieve optimal blood pressure (BP) control. However, BP control attained by number and type of antihypertensive therapy according to CKD stage has not been examined thoroughly.
Study design: Cross-sectional analysis of an electronic medical record (EMR) database.
Setting and participants: A total of 115,608 patients with CKD (Stages 1-4) and diagnosed or treated hypertension in General Electric Centricity EMR from 1996 to 2012.
Outcome: BP control, based on JNC 7 guidelines, was defined as less than 130/80 mm Hg.
Measurements: BP and antihypertensive therapy use was obtained from the EMR. The Cockcroft-Gault equation was used to calculate estimated glomerular filtration rate and classify CKD stage.
Results: Overall prevalence of BP control was 24.3%. BP control varied by CKD stage and number of antihypertensive therapy. In multivariable analysis, younger age was less likely to be associated with BP control, regardless of CKD stage. Multiple antihypertensive therapy use and BP control was strongest among CKD Stage 2 (odds ratio (OR): 1.41; 95% confidence interval (CI): 1.05, 1.90). Diuretic use was less likely to be associated with BP control among CKD Stage 1 (OR: 0.71; 95% CI: 0.59, 0.87) and 2 (OR: 0.78; 95% CI: 0.72, 0.85).
Limitations: Information on antihypertensive prescription fill data and adherence to medication regimens was unavailable.
Conclusions: This study highlighted the need to pay closer attention to achieving BP treatment goals for younger individuals with CKD. More research is needed to assess the extent to which specific combinations of antihypertensive drugs leads to adequate BP control.
Keywords: antihypertensive therapy; blood pressure control; chronic kidney disease; electronic medical record; hypertension..
© American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7. Nephrol Dial Transplant. 2013. PMID: 23658247
-
Blood Pressure Control During Chronic Kidney Disease Progression.Am J Hypertens. 2017 Jun 1;30(6):610-616. doi: 10.1093/ajh/hpx017. Am J Hypertens. 2017. PMID: 28338771
-
CKD awareness and blood pressure control in the primary care hypertensive population.Am J Kidney Dis. 2011 Jan;57(1):71-7. doi: 10.1053/j.ajkd.2010.08.022. Epub 2010 Nov 17. Am J Kidney Dis. 2011. PMID: 21087817
-
Hypertension in Chronic Kidney Disease.Adv Exp Med Biol. 2017;956:307-325. doi: 10.1007/5584_2016_84. Adv Exp Med Biol. 2017. PMID: 27873228 Review.
-
Treatment of hypertension in chronic kidney disease.Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.
Cited by
-
Physical Activity In Renal Disease (PAIRED) and the effect on hypertension: study protocol for a randomized controlled trial.Trials. 2019 Feb 8;20(1):109. doi: 10.1186/s13063-019-3235-5. Trials. 2019. PMID: 30736832 Free PMC article.
-
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).Toxins (Basel). 2018 Jun 12;10(6):237. doi: 10.3390/toxins10060237. Toxins (Basel). 2018. PMID: 29895722 Free PMC article. Review.
-
Terpenes in the management of chronic kidney disease.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6351-6368. doi: 10.1007/s00210-024-03098-4. Epub 2024 Apr 29. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38683370 Review.
-
Predicting Optimal Hypertension Treatment Pathways Using Recurrent Neural Networks.Int J Med Inform. 2020 Jul;139:104122. doi: 10.1016/j.ijmedinf.2020.104122. Epub 2020 Mar 21. Int J Med Inform. 2020. PMID: 32339929 Free PMC article.
-
A feared combination: Hypertension and chronic kidney disease.J Clin Hypertens (Greenwich). 2019 Jan;21(1):102-104. doi: 10.1111/jch.13432. Epub 2018 Nov 14. J Clin Hypertens (Greenwich). 2019. PMID: 30427110 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical